Silver Lake acquired GoodRx in 2018 for $2.80B.

What did Silver Lake pay for GoodRx?

$2.80B, equivalent to 20.7× EBITDA. Target EBITDA was approximately $135.0M.

ACQUIRED · 2018

Who Acquired GoodRx?

Silver Lake · $2.80B· 20.7× EBITDA

GoodRx was acquired by Silver Lake in 2018 for $2.80B. The deal was priced at 20.7× EBITDA.

EBITDA

$135.0M

Deal value

$2.80B

EV / EBITDA

20.7×

University Compounding Pharmacy · acquired by Fagron in 2026 · $41.5M
Choice Specialty Pharmacy Group · acquired by Better Choice Company, Inc. in 2025 · $28.0M
Horizon Infusions · acquired by Rubicon in 2025 · $130.0M
KabaFusion · acquired by Nautic Partners in 2025 · $2.20B
Soleo Health · acquired by Court Square Capital and WindRose Health in 2025 · $1.10B

Three fields, instant range, backed by 25,592 real M&A transactions including this one.